storyUnited StatesHealth CareCapability
Story
OpenAI@
Moderna
Moderna Accelerates Drug Development with ChatGPT Enterprise
Moderna used ChatGPT Enterprise to scale internal GPTs across research and operations, compressing drug-development workflows that previously required an order of magnitude more headcount.
Value results
| Category | Value result |
|---|---|
| Capability | 750 GPTs created in 2 months |
| Capability | Enabled launch of 15 new treatments in 5 years |
| Capability | Operated with thousands of employees instead of a hundred thousand |
Story
Moderna applied ChatGPT Enterprise across the organization so teams could stand up purpose-built GPTs for research, operations, and knowledge work. The featured Valuerepo case highlights how that internal GPT library supported a faster treatment pipeline while keeping the company far smaller than a traditional pharmaceutical workforce of comparable ambition.
OpenAI is featured on Valuerepo as a homepage case rather than a Solutions sidebar vendor.
Zoom
MongoDB
Veeva